These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6829239)

  • 21. The effect of a mast cell degranulating agent on vascular resistance in the human placental vascular bed and on the tone of isolated placental vessels.
    Bytautiene E; Vedernikov YP; Saade GR; Romero R; Garfield RE
    Reprod Sci; 2008 Jan; 15(1):26-32. PubMed ID: 18212351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of Vasodilan on placental blood vessels in vitro].
    Jungmannová C; Hodr J; Zidovský J
    Zentralbl Gynakol; 1973 Oct; 95(42):1476-80. PubMed ID: 4769123
    [No Abstract]   [Full Text] [Related]  

  • 23. Artificial perfusion of the fetal circulation of the in situ mouse placenta: methodology and validation.
    Bond H; Baker B; Boyd RD; Cowley E; Glazier JD; Jones CJ; Sibley CP; Ward BS; Husain SM
    Placenta; 2006 Apr; 27 Suppl A():S69-75. PubMed ID: 16549199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fetal infusions of plasma cause an increase in umbilical vascular resistance in sheep.
    Faber JJ; Anderson DF; Jonker SS; Davis LE; Giraud GD
    Placenta; 2006 Aug; 27(8):876-81. PubMed ID: 16289267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of orciprenaline and papaverine on glucose ultilization in the placenta, perfused in vitro].
    Zrubek H; Oleszczuk J; Pańczyk T; Sawulicka-Oleszczuk H; Dabek W
    Ginekol Pol; 1980 Apr; 51(4):289-94. PubMed ID: 7390246
    [No Abstract]   [Full Text] [Related]  

  • 26. [The regulatory aspects of the blood circulation in the placenta in physiological and complicated pregnancies].
    Gromyko GL; Shpakov AO
    Fiziol Zh (1994); 1997; 43(5-6):126-35. PubMed ID: 9463002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Placental release of corticotrophin-releasing hormone across the umbilical circulation of the human newborn.
    Nodwell A; Carmichael L; Fraser M; Challis J; Richardson B
    Placenta; 1999; 20(2-3):197-202. PubMed ID: 10195742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracorporeal perfusion of the whole human placenta--a new model.
    Maulik D; Contractor SF; Lippes J; Knight A
    Placenta Suppl; 1981; 3():353-65. PubMed ID: 6963967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AA-2414, an antioxidant and thromboxane receptor blocker, completely inhibits peroxide-induced vasoconstriction in the human placenta.
    Walsh SW; Wang Y; Killian A
    J Pharmacol Exp Ther; 1999 Jul; 290(1):220-6. PubMed ID: 10381779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic and toxicity studies of AZT (zidovudine) following perfusion of human term placenta for 14 hours.
    Boal JH; Plessinger MA; van den Reydt C; Miller RK
    Toxicol Appl Pharmacol; 1997 Mar; 143(1):13-21. PubMed ID: 9073587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The dynamic placenta: I. Hypothetical model of a placental mechanism matching local fetal blood flow to local intervillus oxygen delivery.
    Talbert D; Sebire NJ
    Med Hypotheses; 2004; 62(4):511-9. PubMed ID: 15050098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mefloquine transfer during in vitro human placenta perfusion.
    Barzago MM; Omarini D; Bortolotti A; Stellari FF; Lucchini G; Efrati S; Bonati M
    J Pharmacol Exp Ther; 1994 Apr; 269(1):28-31. PubMed ID: 8169835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of lipopolysaccharide on interleukin-6 production in perfused human placental cotyledons.
    Wagner RK; Hinson RM; Apodaca CC; Hoeldtke N; Buchanan T; Hume RF; Calhoun BC
    J Matern Fetal Med; 2000; 9(6):351-5. PubMed ID: 11243293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deep sedation with dexmedetomidine in a porcine model does not compromise the viability of free microvascular flap as depicted by microdialysis and tissue oxygen tension.
    Nunes S; Berg L; Raittinen LP; Ahonen H; Laranne J; Lindgren L; Parviainen I; Ruokonen E; Tenhunen J
    Anesth Analg; 2007 Sep; 105(3):666-72. PubMed ID: 17717221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transplacental pharmacokinetics of diclofenac in perfused human placenta.
    Shintaku K; Hori S; Tsujimoto M; Nagata H; Satoh S; Tsukimori K; Nakano H; Fujii T; Taketani Y; Ohtani H; Sawada Y
    Drug Metab Dispos; 2009 May; 37(5):962-8. PubMed ID: 19204082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fetal placental vascular responses to corticotropin-releasing hormone in vitro. Effects of variation in oxygen tension.
    Donoghue JF; Leitch IM; Boura AL; Walters WA; Giles WB; Smith R; Read MA
    Placenta; 2000 Sep; 21(7):711-7. PubMed ID: 10985975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of prostaglandon F2 alpha on the placental vessels in vitro.
    Jungmannová C; Havránek F; Hodr J
    J Allergy Clin Immunol; 1972 Sep; 50(3):79-80. PubMed ID: 5065710
    [No Abstract]   [Full Text] [Related]  

  • 38. Transfer and use of glucose in the human placenta during in vitro perfusion and the associated effects of oxytocin and papaverine.
    Howard JM; Krantz KE
    Am J Obstet Gynecol; 1967 Jun; 98(4):445-58. PubMed ID: 6067303
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of papaverine on the vasoautoregulation].
    Kisin IE; Chichkanov GG
    Farmakol Toksikol; 1970; 33(4):432-6. PubMed ID: 5525955
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of isoprenaline and orciprenaline on the vascular bed of the mouse placenta.
    Svihovec J; Stulc J; Rychter Z
    Pharmacology; 1978; 16(1):44-8. PubMed ID: 619361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.